GlobalData senior medical device analyst says the acquisition could see Nevro’s growth outside the US accelerate.

Globus Medical is acquiring Nevro Corp, a spinal cord stimulator company, according to a Feb. 6 news release. Globus Medical's transaction will include all shares of Nevro, which are valued at about ...

The spinal implants market is estimated to grow by $3.55 billion from 2025 to 2029, according to research from Technavio.

Nevro's high-frequency neurostimulation cuts diabetic neuropathy pain by 80% in 2-year study Globus aims to add Nevro’s portfolio—with its spinal cord stimulator implants for chronic pain ...

Stryker’s US spinal implants sale to VB Spine creates growth opportunities for competitors like Medtronic and Globus in the ...

Audubon-based Globus Medical has announced its acquisition of California life sciences company Nevro Corp. for $250 million ...

A Florida federal judge has issued a report and recommended that a sales representative pay more than $19 million to resolve ...

The CEO of Globus ... patented HFX spinal cord stimulation platform for treating chronic pain of the trunk and limb as well as diabetic neuropathy. The company also provides minimally invasive ...

The spinal surgical robots market is experiencing rapid growth as healthcare facilities worldwide adopt robotic-assisted technologies for spine surgeries. These robots enhance precision, reduce ...